Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:13 pm Sale |
2024-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Eventide Asset Management, LLC | 4,475,054 6.280% |
-2,615,054 (-36.88%) |
Filing History |
| 2025-02-04 4:06 pm Purchase |
2025-01-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
MILLENNIUM MANAGEMENT LLC | 3,781,298 5.300% |
3,781,298 (New Position) |
Filing History |
| 2025-01-31 12:44 pm Purchase |
2025-01-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Walters William T | 7,050,000 9.900% |
550,000 (+8.46%) |
Filing History |
| 2025-01-31 10:09 am Sale |
2024-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
The Vanguard Group | 3,271,240 4.590% |
-1,341,467 (-29.08%) |
Filing History |
| 2025-01-22 10:08 am Purchase |
2025-01-21 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Walters William T | 6,500,000 9.100% |
1,500,000 (+30.00%) |
Filing History |
| 2025-01-08 6:49 pm Purchase |
2025-01-08 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Walters William T | 5,000,000 7.000% |
1,000,000 (+25.00%) |
Filing History |
| 2024-12-10 12:42 pm Purchase |
2024-12-03 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Walters William T | 4,000,000 5.600% |
4,000,000 (New Position) |
Filing History |
| 2024-12-06 11:44 am Sale |
2024-11-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
FMR CORP | 175,863 0.200% |
-4,899,974 (-96.54%) |
Filing History |
| 2024-11-14 4:20 pm Sale |
2024-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Citadel Advisors LLC | 2,737,221 3.900% |
-1,001,261 (-26.78%) |
Filing History |
| 2024-11-12 6:00 pm Unchanged |
2024-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
The Vanguard Group | 4,612,707 6.480% |
0 (Unchanged) |
Filing History |
| 2024-11-06 2:47 pm Sale |
2024-10-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Eventide Asset Management, LLC | 7,090,108 9.970% |
-4,469,867 (-38.67%) |
Filing History |
| 2024-11-04 2:16 pm Sale |
2024-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
The Vanguard Group | 4,612,707 6.480% |
-737,751 (-13.79%) |
Filing History |
| 2024-10-18 12:50 pm Sale |
2024-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
STATE STREET CORP STT |
1,246,613 1.800% |
-3,170,443 (-71.78%) |
Filing History |
| 2024-10-07 11:37 am Sale |
2024-10-04 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
FMR CORP | 5,075,837 7.138% |
-5,261,134 (-50.90%) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Citadel Advisors LLC | 3,738,482 5.300% |
-101,347 (-2.64%) |
Filing History |
| 2024-02-13 7:43 pm Sale |
2023-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Avidity Partners Management LP | 0 0.000% |
-5,150,000 (Position Closed) |
Filing History |
| 2024-02-13 5:17 pm Purchase |
2023-12-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
The Vanguard Group | 5,350,458 7.560% |
1,190,309 (+28.61%) |
Filing History |
| 2024-02-09 6:05 pm Sale |
2024-02-07 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Capital International Investors | 2,819,664 4.000% |
-228,518 (-7.50%) |
Filing History |
| 2024-02-09 10:05 am Purchase |
2024-02-08 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
FMR CORP | 10,336,971 14.607% |
2,427,795 (+30.70%) |
Filing History |
| 2024-02-09 08:40 am Sale |
2023-12-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
WELLINGTON MANAGEMENT CO LLP | 68,791 0.100% |
-3,549,702 (-98.10%) |
Filing History |